Eric White, MD

Eric White, MD, global clinical development lead for rheumatology and pulmonology at Boehringer Ingelheim Pharmaceuticals

Articles by Eric White, MD

AI CT Tool for Early Pulmonary Fibrosis Detection Enters Phase 3, With Eric White, MD

By Eric White, MD

February 5th 2026

The DROP-FPF Phase 3b trial will use automated HRCT biomarkers to assess whether early treatment with nerandomilast can slow disease progression before lung function declines.

Eric White, MD

Articles by Eric White, MD

AI CT Tool for Early Pulmonary Fibrosis Detection Enters Phase 3, With Eric White, MD

Latest Updated Articles

Trending on HCPLive

Looking Beyond TSH in Hypothyroidism Management, With Rosemarie Lajara, MD

Tips on Treating Hemangiomas and Molluscum Contagiosum in Children, With Lisa Swanson, MD

Key Diagnostic and Therapeutic Pearls for Connective Tissue Disease, With Michelle Min, MD

Identifying Confounders in Persistent Hypothyroidism Symptoms, With Rosemarie Lajara, MD

Dapagliflozin Reduces Insulin Requirements at Discharge After CABG in Patients With T2D